Semaglutide demonstrated unpre 2 obesity trial 16.2% weight reduction with the highest semaglutide dose in phase 2 obesity trial Change in body weight 0% -3% -6% -9% -12% -15% -18% 0 2 4 6 8 10 12 14 16 18 20 24 28 32 36 40 44 48 52 Weeks sema 0.05 mg sema 0.4 mg sema 0.1 mg lira 3.0 mg sema 0.2 mg Placebo sema 0.3 mg
Download PDF file